|
1
|
Kumar MR: Chromobacterium violaceum: A
rare bacterium isolated from a wound over the scalp. Int J Appl
Basic Med Res. 2:70–72. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Alim R, Safiullah SA, Munwar S, Mazhar I,
Zaman SU and Bari S: Wound Infection Caused by Chromobacterium
violaceum: A Case Report from a Tertiary Care Hospital in
Bangladesh. Adv Microbiol. 12:83–89. 2022.
|
|
3
|
Lee J, Kim JS, Nahm CH, Choi JW, Kim J,
Pai SH, Moon KH, Lee K and Chong Y: Two Cases of Chromobacterium
violaceum Infection after Injury in a Subtropical Region. J Clin
Microbiol. 37:2068–2070. 1999.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sharmin S, Jahan AA, Kamal SMM and Sarker
P: Fatal Infection Caused by Chromobacterium violaceum : A Case
Report from a Tertiary Care Hospital in Bangladesh. Case Rep Infect
Dis. 2019(6219295)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
de Siqueira IC, Dias J, Ruf H, Ramos EA,
Maciel EA, Rolim A, Labur L, Vasconcelos L and Silvany C:
Chromobacterium violaceum in Siblings, Brazil. Emerg Infect Dis.
11:1443–1445. 2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Park JW, Lee SJ, Kim JE, Kang MJ, Bae SJ,
Choi YJ, Gong JE, Kim KS, Jung YS, Cho JY, et al: Comparison of
response to LPS-induced sepsis in three DBA/2 stocks derived from
different sources. Lab Anim Res. 37(2)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Venkatramanan M and Nalini E: Regulation
of virulence in Chromobacterium violaceum and strategies to combat
it. Front Microbiol. 15(1303595)2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Naga NG, El-Badan DE, Ghanem KM and
Shaaban MI: It is the time for quorum sensing inhibition as
alternative strategy of antimicrobial therapy. Cell Commun Signal.
21(133)2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Venkatramanan M, Sankar Ganesh P, Senthil
R, Akshay J, Veera Ravi A, Langeswaran K, Vadivelu J, Nagarajan S,
Rajendran K and Shankar EM: Inhibition of Quorum Sensing and
Biofilm Formation in Chromobacterium violaceum by Fruit Extracts of
Passiflora edulis. ACS Omega. 5:25605–25616. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mion S, Carriot N, Lopez J, Plener L,
Ortalo-Magné A, Chabrière E, Culioli G and Daudé D: Disrupting
quorum sensing alters social interactions in Chromobacterium
violaceum. NPJ Biofilms Microbiomes. 7(40)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sathishkumar K: Revitalising healthcare:
The role of natural products in modern medicine. Natural Product
Research. 1-3:2024.
|
|
12
|
Karunamoorthi K, Jegajeevanram K,
Vijayalakshmi J and Mengistie E: Traditional medicinal plants: A
source of phytotherapeutic modality in resource-constrained health
care settings. J Evid Based Complement Alternat Med. 18:67–74.
2013.
|
|
13
|
Venkatesan LS, Gunasekaran V and
Sathishkumar P: Combating dental biofilms using plant-derived
flavonoids: A simple and potential therapeutic approach. Nat Prod
Res: Oct 1, 2024 (Epub ahead of print).
|
|
14
|
Rao GN, Nagender A, Satyanarayana A and
Rao DG: Preparation, chemical composition and storage studies of
quamachil (Pithecellobium dulce L.) aril powder. J Food Sci
Technol. 48:90–95. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Orwa C, Mutua A, Kindt R, Jamnadass R and
Simons A: Agroforestree database: A tree species reference and
selection guide version 4.0. World Agroforestry Centre ICRAF,
Nairobi, KE, 2009.
|
|
16
|
Saxena VK and Singhal M: Novel prenylated
flavonoid from stem of Pithecellobium dulce. Fitoterapia.
70:98–100. 1999.
|
|
17
|
Govindarajan M, Sivakumar R, Rajeswari M
and Yogalakshmi K: Chemical composition and larvicidal activity of
essential oil from Mentha spicata (Linn.) against three mosquito
species. Parasitol Res. 110:2023–2032. 2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Pithayanukul P, Ruenraroengsak P, Bavovada
R, Pakmanee N, Suttisri R and Saen-oon S: Inhibition of Naja
kaouthia venom activities by plant polyphenols. J Ethnopharmacol.
97:527–533. 2005.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Pradeepa S, Subramanian S and Kaviyarasan
V: Evaluation of antimicrobial activity of Pithecellobium dulce pod
pulp extract. Asian J Pharm Clin Res. 7 (Suppl 1):S32–S37.
2014.
|
|
20
|
Pincus D.H: Microbial Identification Using
the Biomerieux VITEK 2 System. In: Encyclopedia of Rapid
Microbiological Methods. Miller MJ (Ed). pp1-32, 2013.
|
|
21
|
August PR, Grossman TH, Minor C, Draper
MP, MacNeil IA, Pemberton JM, Call KM, Holt D and Osburne MS:
Sequence analysis and functional characterization of the violacein
biosynthetic pathway from Chromobacterium violaceum. J Mol
Microbiol Biotechnol. 2:513–519. 2000.PubMed/NCBI
|
|
22
|
Soni M, Naseef Pathoor N, Viswanathan A,
Veeraragavan GR and Sankar Ganesh P: Exploring the antimicrobial
and antibiofilm activities of Artocarpus heterophyllus Lam. against
Pseudomonas aeruginosa PAO1. World Acad Sci J. 6(50)2024.
|
|
23
|
Barnes P, Gonzales J and Hammond D:
Chromobacterium violaceum : A rare opportunistic pathogen and clue
for pediatric chronic granulomatous disease. Pediatr Dermatol.
40:396–397. 2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Batista JH and Silva Neto JF:
Chromobacterium violaceum Pathogenicity: Updates and insights from
genome sequencing of novel chromobacterium species. Front
Microbiol. 8(2213)2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sushma PG, Adimulapu Hima Sandeep, Saritha
Bhandari and Ashwini Anil Pokle: Evaluation of antibacterial
potential of Pithecellobium dulce against Streptococcus mutans. J
Pop Ther Clin Pharm. 30:58–64. 2023.
|
|
26
|
Aldarhami A, Bazaid AS, Alhamed AS,
Alghaith AF, Ahamad SR, Alassmrry YA, Alharazi T, Snoussi M, Qanash
H, Alamri A, et al: Antimicrobial potential of pithecellobium dulce
seed extract against pathogenic bacteria: In silico and in vitro
evaluation. Biomed Res Int. 2023(2848198)2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Shinde S, Lee LH and Chu T: Inhibition of
Biofilm Formation by the Synergistic Action of EGCG-S and
Antibiotics. Antibiotics (Basel). 10(102)2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Brackman G, Cos P, Maes L, Nelis HJ and
Coenye T: Quorum sensing inhibitors increase the susceptibility of
bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob
Agents Chemother. 55:2655–2661. 2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hawas S, Verderosa AD and Totsika M:
Combination therapies for biofilm inhibition and eradication: A
comparative review of laboratory and preclinical studies. Front
Cell Infect Microbiol. 12(850030)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Selvaraj K, Venkatesan LS, Ganapathy D and
Sathishkumar P: Treatment of dental biofilm-forming bacterium
Streptococcus mutans using tannic acid-mediated gold nanoparticles.
Microb Pathog. 189(106568)2024.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Mathew MZ, Arthanari A, Ganesh S, Naseef
Pathoor N, Ramalingam K and Ravindran V: Evaluating the efficacy of
actinidia deliciosa (Kiwi Fruit) extract in inhibiting pseudomonas
aeruginosa biofilm formation: An in vitro study with therapeutic
implications. Cureus. 16(e70082)2024.PubMed/NCBI View Article : Google Scholar
|
|
32
|
El-hewehy A, Mohsen E, El-fishawy AM and
Fayed MAA: Traditional, Phytochemical, Nutritional and Biological
Importance of Pithecellobium dulce (Roxib.) Benth. Yüzüncü Yıl
Üniversitesi Tarım Bilimleri Dergisi. 34:354–380. 2024.
|
